600 related articles for article (PubMed ID: 25326585)
1. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
[TBL] [Abstract][Full Text] [Related]
2. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
Xie J; Yoon J; An SW; Kuro-o M; Huang CL
J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
[TBL] [Abstract][Full Text] [Related]
3. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
4. Klotho Deficiency and the Cardiomyopathy of Advanced CKD.
Floege J; Fliser D
J Am Soc Nephrol; 2015 Jun; 26(6):1229-31. PubMed ID: 25326584
[No Abstract] [Full Text] [Related]
5. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
Grabner A; Faul C
Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
[TBL] [Abstract][Full Text] [Related]
6. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
7. The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human.
Liu Q; Zhu LJ; Waaga-Gasser AM; Ding Y; Cao M; Jadhav SJ; Kirollos S; Shekar PS; Padera RF; Chang YC; Xu X; Zeisberg EM; Charytan DM; Hsiao LL
J Mol Cell Cardiol; 2019 Nov; 136():113-124. PubMed ID: 31520610
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts.
Leifheit-Nestler M; Kirchhoff F; Nespor J; Richter B; Soetje B; Klintschar M; Heineke J; Haffner D
Nephrol Dial Transplant; 2018 Oct; 33(10):1722-1734. PubMed ID: 29425341
[TBL] [Abstract][Full Text] [Related]
9. Dietary vitamin D interacts with high phosphate-induced cardiac remodeling in rats with normal renal function.
Hu MC; Scanni R; Ye J; Zhang J; Shi M; Maique J; Flores B; Moe OW; Krapf R
Nephrol Dial Transplant; 2020 Mar; 35(3):411-421. PubMed ID: 31504790
[TBL] [Abstract][Full Text] [Related]
10. A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy.
Bao JF; Hu PP; She QY; Li A
J Am Soc Nephrol; 2020 Jul; 31(7):1423-1434. PubMed ID: 32527977
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
Xie J; Wu YL; Huang CL
Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
[TBL] [Abstract][Full Text] [Related]
12. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
[TBL] [Abstract][Full Text] [Related]
13. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
14. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
[TBL] [Abstract][Full Text] [Related]
15. New insights into the FGF23-Klotho axis.
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
[TBL] [Abstract][Full Text] [Related]
16. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.
Navarro-García JA; Salguero-Bodes R; González-Lafuente L; Martín-Nunes L; Rodríguez-Sánchez E; Bada-Bosch T; Hernández E; Mérida-Herrero E; Praga M; Solís J; Arribas F; Bueno H; Kuro-O M; Fernández-Velasco M; Ruilope LM; Delgado C; Ruiz-Hurtado G
BMC Med; 2022 Jan; 20(1):14. PubMed ID: 35042527
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure.
Chen K; Wang S; Sun Z
Transl Res; 2022 Jun; 244():101-113. PubMed ID: 35114419
[TBL] [Abstract][Full Text] [Related]
18. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
[TBL] [Abstract][Full Text] [Related]
19. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.
Nordholm A; Egstrand S; Gravesen E; Mace ML; Morevati M; Olgaard K; Lewin E
Pflugers Arch; 2019 Aug; 471(8):1079-1094. PubMed ID: 31236663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
